Target intelligence / Profile preview

Circadian locomotor output cycles protein kaput (CLOCK)

Target
CLOCK
Molecular classification
Transcription factor, Histone acetyltransferase
01

Overview

Circadian locomotor output cycles protein kaput (CLOCK) is a core transcription factor in the molecular circadian clock system. It forms a heterodimer with BMAL1, and this complex drives expression of PER and CRY genes by binding E-box elements in target gene promoters, generating the feedback loops that maintain circadian rhythms in mammalian physiology[1][2]. CLOCK is also a histone acetyltransferase, providing chromatin-regulatory functions that are essential for rhythmic gene transcription[1]. Its activity modulates processes such as sleep/wake timing, hormone secretion, metabolism, inflammation, DNA repair, and the cell cycle[2]. Dysfunction of CLOCK has been linked to cancer, neurodegeneration, cardiovascular and metabolic diseases, and inflammatory pathologies[2]. Drugs directly targeting CLOCK are experimental, but manipulation of its pathway has potential therapeutic utility; however, risks include widespread biological disruption given its centrality to human physiology[2].

Other names
CLOCKBHLHE8KIAA0334KAT13DhCLOCKbHLHe8class E basic helix-loop-helix protein 8
02

Mechanism of action

Direct or indirect inhibition of CLOCK/BMAL1 activity; Modulation of transcription or acetylation activity affecting downstream circadian output

03

Biological functions

Regulation of circadian rhythmsGene transcriptionCell cycle controlDNA damage responseRegulation of inflammation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationMetabolic disease
05

Safety considerations

Potential broad systemic effects due to disruption of circadian clock function across tissuesRisks of sleep and mood disordersMetabolic disturbances
06

Interacting drugs

No approved drugs specifically target CLOCK directly as of now; some experimental compounds, such as small-molecule modulators of core clock proteins or histone acetyltransferase inhibitors, have been investigated in preclinical contexts.
07

Biomarkers

Changes in PER1, PER2, CRY1, or CRY2 expression (downstream circadian genes)Disrupted circadian gene expression signatures

Beyond the preview

Go deeper on Circadian locomotor output cycles protein kaput (CLOCK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circadian locomotor output cycles protein kaput (CLOCK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call